Sunday, 01 July 2012
1:52
MDA - AVI BioPharma Exon-Skipping Clinical Trial
AVI BioPharma opened a phase 2 trial of its exon-skipping drug eteplirsen on Aug. 15, 2011...
published: 15 Aug 2011
author: MySpaceMDA
58:43
AVI Clinical Trial Update Webinar
Parent Project Muscular Dystrophy's AVI webinar covers a pre-data update on AVI BioPha...
published: 22 Mar 2012
4:50
AVI BioPharma (AVII) US Stock to Watch
The AVI BioPharma chart is holding a support level at 75 cents. A bullish harami 2-day can...
published: 09 May 2012
19:31
A New Model for Drug Development in Rare Disease: Gaining Approval as a Class / Chris Garabedian, Pr
* How can genetic-based drug development deliver on the promise of personalized medicine *...
published: 04 Feb 2012
4:19
AVI BioPharma, Inc. (NASDAQ:AVII)
The AVII stock chart is holding a support level right on top of the 200 day simple moving ...
published: 28 Feb 2011
author: PennyPayDay
0:38
AVI BioPharma Initiated at Buy at WBB Securities; $3 PT (AVII)
AVI BioPharma, Inc. (NASDAQ:AVII) was initiated with a Speculative Buy rating at WBB Secur...
published: 29 Dec 2010
0:41
News Update: Shares of AVI BioPharma, Inc. Up Pre-Market
Shares of AVI BioPharma, Inc. (NASDAQ:AVII) rallied before market-open Monday morning, fol...
published: 23 Aug 2010
0:31
AVI BioPharma Tumbles After Pricing IPO (AVII)
Shares of AVI BioPharma (NASDAQ:AVII) were trading down nearly 18% Friday after the compan...
published: 01 Apr 2011
3:02
The Ebola Needle Stick
Dr. Pat Iversen of AVI BioPharma discusses how AVI created a therapeutic for Ebola in five...
published: 15 Sep 2011
1:35
Rapid Response Success on West Nile Virus
Dr. Pat Iversen of AVI BioPharma discusses how AVI developed a therapeutic to save penguin...
published: 17 Sep 2011
1:39
Contagion
Dr. Pat Iversen of AVI BioPharma discusses the movie 'Contagion' and the reality o...
published: 15 Sep 2011
5:48
Dr. Ed Kaye on ALS and the Incentive Prize Model
Dr. Ed Kaye, the Chief Medical Officer at AVI BioPharma and former Group Vice President an...
published: 17 Oct 2011
author: Prize4Life
2:05
BioAsia 2011 - Dr. Vinod Kubrekar - Head, Contract services, Intas Biopharma.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
6:38
Bridging patients and researchers to advance research in rare diseases.
Dr. Ryszard Kole is a researcher whose work led to a discovery that splicing provides a no...
published: 16 Feb 2010
author: eurordis
10:28
ECYC, IMOS, RVSN, DECK, ALK - Stock Charts - Harry Boxer, TheTechTrader.com
03/14/12 - It was an interesting day on Wall Street on Wednesday. There's rarely a day...
published: 15 Mar 2012
8:10
Equity Technical Analysis Review For Friday 10/13/06
Technical analysis of previously mentioned individual stocks trading ideas including; Bruk...
published: 13 Oct 2006
author: thermal1
4:39
BioAsia2011- CEO Conclave- Utkarsh Palnitkar.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
14:18
BioAsia 2011- Exhibition.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
9:47
BioAsia 2011- Valedictory Ceramony - His Excellency Shri ESL Narasimhan- Governor of AP.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
6:41
BioAsia 2011 Inaugural- Welcome Address - Prof. Seyed E. Hasnain.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
8:08
BioAsia 2011- Valedictory Ceramony - Prof. D. Balasubramanian.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
11:20
BioAsia2011- CEO Conclave- Dr. Bobba Venkatadri.avi
BioAsia 2011, Hyderabad, India...
published: 12 Jul 2011
author: fababioasia
10:28
ECYC, IMOS, RVSN, DECK, ALK - Stock Charts - Harry Boxer, TheTechTrader.com
thetechtrader
8:10
Equity Technical Analysis Review For Friday 10/13/06
thermal1
4:39
BioAsia2011- CEO Conclave- Utkarsh Palnitkar.avi
fababioasia
14:18
BioAsia 2011- Exhibition.avi
fababioasia
9:47
BioAsia 2011- Valedictory Ceramony - His Excellency Shri ESL Narasimhan- Governor of AP.avi
fababioasia
6:41
BioAsia 2011 Inaugural- Welcome Address - Prof. Seyed E. Hasnain.avi
fababioasia
show more
add to playlist
clear







The World News (WN) Network, has created this privacy statement in order to demonstrate our firm commitment to user privacy. The following discloses our information gathering and dissemination practices for wn.com, as well as e-mail newsletters.

1. Personal Information Collection and Use

We do not collect personally identifiable information about you, except when you provide it to us. For example, if you submit an inquiry to us or sign up for our newsletter, you may be asked to provide certain information such as your contact details (name, e-mail address, mailing address, etc.).

When you submit your personally identifiable information through wn.com, you are giving your consent to the collection, use and disclosure of your personal information as set forth in this Privacy Policy. If you would prefer that we not collect any personally identifiable information from you, please do not provide us with any such information. We will not sell or rent your personally identifiable information to third parties without your consent, except as otherwise disclosed in this Privacy Policy.

Except as otherwise disclosed in this Privacy Policy, we will use the information you provide us only for the purpose of responding to your inquiry or in connection with the service for which you provided such information. We may forward your contact information and inquiry to our affiliates and other divisions of our company that we feel can best address your inquiry or provide you with the requested service. We may also use the information you provide in aggregate form for internal business purposes, such as generating statistics and developing marketing plans. We may share or transfer such non-personally identifiable information with or to our affiliates, licensees, agents and partners.

We may retain other companies and individuals to perform functions on our behalf. Such third parties may be provided with access to personally identifiable information needed to perform their functions, but may not use such information for any other purpose.

In addition, we may disclose any information, including personally identifiable information, we deem necessary, in our sole discretion, to comply with any applicable law, regulation, legal proceeding or governmental request.

2. E-mail addresses

We do not want you to receive unwanted e-mail from us. We try to make it easy to opt-out of any service you have asked to receive. If you sign-up to our e-mail newsletters we do not sell, exchange or give your e-mail address to a third party.

E-mail addresses are collected via the wn.com web site. Users have to physically opt-in to receive the wn.com newsletter and a verification e-mail is sent. wn.com is clearly and conspicuously named at the point of

collection.

If you no longer wish to receive our newsletter and promotional communications, you may opt-out of receiving them by following the instructions included in each newsletter or communication or by e-mailing us at michaelw(at)wn.com

The security of your personal information is important to us. We follow generally accepted industry standards to protect the personal information submitted to us, both during registration and once we receive it. No method of transmission over the Internet, or method of electronic storage, is 100 percent secure, however. Therefore, though we strive to use commercially acceptable means to protect your personal information, we cannot guarantee its absolute security.

If we decide to change our e-mail practices, we will post those changes to this privacy statement, the homepage, and other places we think appropriate so that you are aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it.

If we make material changes to our e-mail practices, we will notify you here, by e-mail, and by means of a notice on our home page.

3. Third Party Advertisers

The advertising banners and other forms of advertising appearing on this Web site are sometimes delivered to you, on our behalf, by a third party. In the course of serving advertisements to this site, the third party may place or recognize a unique cookie on your browser. For more information on cookies, you can visit www.cookiecentral.com.

4. Business Transfers

As we continue to develop our business, we might sell certain aspects of our entities or assets. In such transactions, user information, including personally identifiable information, generally is one of the transferred business assets, and by submitting your personal information on Wn.com you agree that your data may be transferred to such parties in these circumstances.